GHRP-6 (Growth Hormone Releasing Peptide-6): preparation and storage
Intended for research use only. Not a medicinal product.
Contents (11 sections)
GHRP-6 is not a growth hormone fragment
GHRP-6 is a synthetic hexapeptide secretagogue and agonist of the ghrelin receptor GHS-R1a. It is not a segment of the growth hormone sequence or a substitute for growth hormone in a biochemical assay. Its activity depends on a specific sequence, D-amino acids and C-terminal amidation. Six residues or a similar nominal mass alone do not establish identity. The certificate must refer to GHRP-6 rather than GHRP-2 or a secretagogue mixture. Prepare these compounds separately in comparative experiments and establish molar concentrations from each confirmed form.
Batch identity and supplied form
Before opening, match the vial name, batch number, certificate of analysis and specification. Establish identity, stated mass, counterion, water, excipients and recommended conditions. “Lyophilized” describes a drying process; it does not establish purity, sterility or exact peptide content. HPLC main-peak area and peptide mass fraction are different measurements: water and salts may contribute little to that chromatogram. If the manufacturer has not established peptide content, label the concentration as calculated from nominal mass.
What the ipamorelin comparison establishes
Raun and colleagues used GHRP-6 as a comparator in primary rat pituitary cells and animal models. They measured GH secretion and, in swine, other hormonal endpoints. Model choice determines what “active sample” means. A receptor reporter can support batch checks but does not reproduce every step of pituitary secretion. Reproducing a published result requires corresponding biological material; routine quality control can use a simpler validated endpoint that is explicitly identified. Animal-study values are not standard concentrations for every cell line.
Aromatic residues and working dilutions
GHRP-6 contains tryptophan and aromatic residues, so solution validation extends beyond the initial disappearance of powder. Check material after transfer from stock to receptor-assay buffer, particularly when pH and protein content change. Assess low-concentration losses in plates and tips separately. A small sample can compare ordinary and low-binding plastic with chemical recovery measurements. Reduced recovery after dilution does not establish degradation when a substantial fraction remains on surfaces or in precipitate.
Mass calculations and working dilutions
An arithmetic example, not a solubility prescription: 2 mg in a final volume of 4 mL gives 0.5 mg/mL, or 500 micrograms/mL. Adding 20 microliters of that stock to 980 microliters of compatible matrix gives 10 micrograms/mL. Then 100 microliters of this solution plus 900 microliters of matrix gives 1 microgram/mL. Use the final volume in the calculation. If the certificate separately establishes peptide mass fraction, apply it according to the labeling convention, without correcting the mass twice. Molarity requires the molecular weight of the confirmed form; do not borrow a value from a related analogue.
Receptor signaling and GH secretion answer different questions
A GHS-R1a cell system can measure signaling, such as calcium mobilization, while a pituitary model can measure GH secretion. These are different biological levels. Failure to detect GH in a system without the relevant secretory cells is not evidence of reagent failure. Receptor assays need receptor-expression controls, a vehicle control, a fresh positive control and viability assessment. Account for the intrinsic basal activity of GHS-R1a and readout timing. Compare concentration-response curves at the same incubation time; changed kinetics can appear to be changed potency.
Unlabeled GHRP-6 and analytical signals
GHRP-6 tryptophan can provide UV or fluorescence signals, but intensity depends on method and medium. Do not use another secretagogue’s extinction coefficient. In protein-containing medium, protein contributions may exceed the peptide signal, so total absorbance does not separate components. Recovery checks after plastic contact need a method that measures GHRP-6 specifically. If dissolved quantity falls, consider precipitation and surface binding. This is distinct from looking for an oxidation product; one procedure may not answer both questions.
Oxidation and stability questions
Do D-residues guarantee stability in any medium? They do not eliminate adsorption, oxidation or matrix effects. Tryptophan warrants control of light and oxidizing conditions, rather than an arbitrary expiry date. Can working GHRP-6 be stored with a GHRH analogue? Treat that mixture as a new matrix and validate it separately; stability of individual components does not establish mixture stability. Investigate signal loss by comparing fresh GHRP-6, the stored sample and cell controls in the same series rather than on different days.
Organizing stocks for a receptor series
Store dry GHRP-6 frozen under the batch specification and equilibrate the sealed vial before opening. Plan working stocks to avoid thawing all material for each plate when solution freezing has been validated. Include a consistent fresh control point or reference lot in a multiday series. If every agonist loses maximum signal, first check the cells and reader rather than attributing the effect only to GHRP-6 degradation. If only its curve changes, compare chemical recovery and dilution conditions.
Sources and scope
End of article
GHRP-6
for laboratory research
Packs and current prices on the product page.